COMMUNIQUÉS West-GlobeNewswire

De jeunes leaders transmettent des compétences qui sauvent des vies aux élèves du primaire : Le programme de RCR et DEA au secondaire d’ACT en action
11/05/2026
BRAMPTON, Ontario, 11 mai 2026 (GLOBE NEWSWIRE) -- Des élèves leaders de l’école secondaire Jean Augustine ont initié plus de 100 élèves de 8ème année de l’école publique Eldorado à la réanimation cardiorespiratoire ( [...]
Portsmouth Square, Inc. Reports Third Quarter Fiscal 2026 Results; Hotel Operating Results Improve Year‑Over‑Year as San Francisco Recovery Progresses
11/05/2026
Los Angeles, California, May 11, 2026 (GLOBE NEWSWIRE) -- Portsmouth Square, Inc. (the “Company” or “Portsmouth”) today announced financial results for the fiscal third quarter ended March 31, 2026. Portsmouth’s [...]
110 Years. 110 Stories. 110 Reasons to Raise Awareness for GBS
11/05/2026
CONSHOHOCKEN, Pa., May 11, 2026 (GLOBE NEWSWIRE) -- May is GBS|CIDP Awareness Month and this year marks 110 years since the discovery of Guillain-Barré syndrome (GBS), which was first identified and named in 1916 by [...]
IBA – ACQUISITION OF OWN SHARES
11/05/2026
Louvain-la-Neuve, Belgium, May 11 th , 2026 – 6 PM CEST – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) [...]
Pheast Therapeutics Presents Preclinical Data on PHST677, a Novel Bispecific ADC Targeting CDH1 and Nectin-4 at PEGS Boston Summit 2026
11/05/2026
Preclinical data demonstrate a differentiated bispecific ADC design through E-cadherin blockade and Nectin-4 targeting REDWOOD CITY, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Pheast Therapeutics , a clinical-stage [...]
NexTel Medical Corp Enters Final Stage for Commercial Launch; Sets Sights on Revenue Generation and OTCQB Uplist
11/05/2026
ORLANDO, Fla., May 11, 2026 (GLOBE NEWSWIRE) -- NexTel Medical Corp (f/k/a Exousia Pro, Inc.) (OTCPK: MAJI) , a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery systems, is excited [...]
Lumenis Stellar M22™ with XPL Technology Named “Best New Dermatology Technology Solution” in 2026 MedTech Breakthrough Awards Program
11/05/2026
Landmark 10th Annual Awards Program Recognizes the Most Innovative Digital Health and Medical Technology Solutions Worldwide LOS ANGELES, May 11, 2026 (GLOBE NEWSWIRE) -- MedTech Breakthrough , an independent market [...]
IBA – ACQUISITION D’ACTIONS PROPRES
11/05/2026
Louvain-la-Neuve, Belgique, 11 mai 2026 – 18h00 – Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam Applications SA ("IBA") communique [...]
Cytokinetics Announces New Data Related to MYQORZO® (aficamten) at ESC Heart Failure 2026
11/05/2026
Multinational Real-world Data Reinforce Favorable Clinical Profile and Long-Term Safety SOUTH SAN FRANCISCO, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the [...]
Progyny, Inc. to Present at BofA Securities 2026 Health Care Conference
11/05/2026
NEW YORK, May 11, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that Progyny’s Chief Executive Officer, Pete Anevski, and Chief [...]
Bavarian Nordic Awarded Contract Options from the U.S. Government for Production and Supply of Freeze-dried Smallpox Vaccines
11/05/2026
Exercised options total USD 97 million, covering manufacturing of bulk vaccine and supply of freeze-dried vaccines. Company upgrades full-year financial guidance COPENHAGEN, Denmark, May 11, 2026 – Bavarian Nordic A/S ( [...]
Fagron shareholders approve all proposed resolutions at the General Meetings
11/05/2026
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 11 May 2026 – 6PM CET Fagron shareholders approve all proposed resolutions at the General Meetings Fagron, the leading global player in [...]
Fate Therapeutics Showcases FT819 Clinical Activity in SLE without the use of Conditioning Chemotherapy at the 2026 ASGCT Annual Meeting
11/05/2026
Single dose treatment of FT819 without conditioning chemotherapy achieves lupus low disease activity state (LLDAS) in active SLE Patients; durable B cell remodeling is exhibited by depletion of major B cell clones up to [...]
The Future of Intoxication Detection May Be in Your Voice
11/05/2026
AUSTIN, Texas, May 11, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage : The ability to accurately detect drug and alcohol intoxication has long been a persistent challenge across industries, from law enforcement [...]
The Next Generation of the GLP-1 Revolution Is Already Underway
11/05/2026
AUSTIN, Texas, May 11, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage : Obesity and type 2 diabetes mellitus (T2DM) have become two of the most pressing healthcare challenges worldwide, driving rising rates of [...]
AGC Biologics Joins Orphan Therapeutics Accelerator’s Clinical Development Network as a Manufacturing Partner to Advance Cell and Gene Therapies for Ultra-Rare Diseases
11/05/2026
Collaboration brings AGC Biologics’ advanced therapy expertise and global footprint to OTXL’s network, supporting a sustainable path from clinical development to commercial access for therapies serving the smallest [...]
Cruise Ship Virus Outbreaks Highlight Massive Emerging Demand for TOMI Environmental Solutions’ SteraMist Technology
11/05/2026
Rising Norovirus, Hantavirus, and Pandemic-Era Infection Fears Could Create a Multi-Billion-Dollar Opportunity Across Cruise Ships, Hotels, Hospitals, Airports and Commercial Facilities FREDERICK, Md., May 11, 2026 ( [...]
FibroBiologics Advancing Development of a Fibroblast Treatment for Hantavirus
11/05/2026
Will Apply Existing Preclinical Findings in Reducing Severe Immune-Mediated Lung Failure to Potential Emerging Global Crisis HOUSTON, May 11, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics [...]
Disc Medicine to Participate in Upcoming Investor Conferences
11/05/2026
WATERTOWN, Mass., May 11, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for [...]

Pages